ID SIHN-005A AC CVCL_W318 DR Wikidata; Q54953474 RX PubMed=10760816; RX PubMed=11497283; RX PubMed=12124801; CC Doubling time: 38.0 +- 1.1 hours (PubMed=11497283). CC Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723. DI NCIt; C4648; Tongue squamous cell carcinoma DI ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue OX NCBI_TaxID=9606; ! Homo sapiens (Human) OI CVCL_W319 ! SIHN-005B SX Male AG 57Y CA Cancer cell line DT Created: 16-04-14; Last updated: 29-06-23; Version: 9 // RX PubMed=10760816; DOI=10.1002/(SICI)1097-0215(20000501)86:3<307::AID-IJC2>3.0.CO;2-I; RA O-Charoenrat P., Rhys-Evans P.H., Modjtahedi H., Court W., Box G., RA Eccles S.A.; RT "Overexpression of epidermal growth factor receptor in human head and RT neck squamous carcinoma cell lines correlates with matrix RT metalloproteinase-9 expression and in vitro invasion."; RL Int. J. Cancer 86:307-317(2000). // RX PubMed=11497283; RA O-Charoenrat P., Rhys-Evans P.H., Eccles S.A.; RT "Characterization of ten newly-derived human head and neck squamous RT carcinoma cell lines with special reference to c-erbB proto-oncogene RT expression."; RL Anticancer Res. 21:1953-1963(2001). // RX PubMed=12124801; DOI=10.1002/ijc.10531; RA O-Charoenrat P., Rhys-Evans P.H., Eccles S.A.; RT "A synthetic matrix metalloproteinase inhibitor prevents squamous RT carcinoma cell proliferation by interfering with epidermal growth RT factor receptor autocrine loops."; RL Int. J. Cancer 100:527-533(2002). //